results News newsbot.ch

Wirtschaft »

FDA approves cobas Babesia, Roche’s first whole blood test for donor screening

2019-09-20 07:40:10


Wirtschaft »

FDA grants Breakthrough Therapy Designation for Roche’s Gazyva (obinutuzumab) in Lupus Nephritis

2019-09-18 05:20:01


Wirtschaft »

Roche receives FDA clearance for cobas pro integrated solutions designed to help labs deliver faster results to patients

2019-09-16 05:20:45


Wirtschaft »

Roche presents new 6-year OCREVUS (ocrelizumab) data which showed that earlier initiation and continuation of treatment reduced disability progression in multiple sclerosis

2019-09-13 13:20:50


Wirtschaft »

Roche’s satralizumab significantly reduced relapse risk in second  positive phase III study for neuromyelitis optica spectrum

Roche’s satralizumab significantly reduced relapse risk in second positive phase III study for neuromyelitis optica spectrum

2019-09-12 13:20:00


Wirtschaft »

Roche to present pivotal data for satralizumab in neuromyelitis optica spectrum disorder and six-year OCREVUS data in multiple sclerosis at ECTRIMS

2019-09-04 06:40:12


Wirtschaft »

Positive phase III results show Xofluza reduces risk of developing flu after contact with an infected person by 86%

2019-09-02 22:40:14


Wirtschaft »

Roche presents positive phase III study results for one-dose Xofluza in children with flu

2019-09-02 22:40:14


Wirtschaft »

European Commission approves Roche’s Tecentriq in combination with Abraxane for people with PD-L1-positive, metastatic triple-negative breast cancer

2019-08-29 07:40:16


Wirtschaft »

FDA approves Roche’s Rozlytrek (entrectinib) for people with ROS1-positive, metastatic non-small cell lung cancer and NTRK gene fusion-positive solid tumours

2019-08-16 16:40:40


Wirtschaft »

Roche’s Tecentriq plus platinum-based chemotherapy reduced the risk of disease worsening or death in people with previously untreated advanced bladder cancer

2019-08-05 05:40:23


Wirtschaft »

Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc.

2019-07-31 09:24:45


Wirtschaft »

CHMP recommends EU approval of Roche’s Tecentriq in combination with chemotherapy as an initial treatment of adults with extensive-stage small cell lung cancer

2019-07-26 11:20:11


Wirtschaft »

Roche presents a broad range of data for Hemlibra demonstrating continued benefits for people with haemophilia A at the ISTH 2019 Congress

Roche presents a broad range of data for Hemlibra demonstrating continued benefits for people with haemophilia A at the ISTH 2019 Congress

2019-07-09 09:20:15


Wirtschaft »

CHMP recommends EU approval of Roche’s Tecentriq in combination with Abraxane as an initial treatment for people with PD-L1-positive, metastatic triple-negative breast cancer

2019-06-28 12:20:05


Wirtschaft »

FDA grants Roche’s Polivy accelerated approval for people with previously treated aggressive lymphoma

2019-06-11 14:40:06


Wirtschaft »

Roche and Spark Therapeutics, Inc. receive Request for Additional Information from FTC under Hart-Scott-Rodino Act and announce extension of tender offer for shares of Spark Therapeutics, Inc.

2019-06-10 12:40:00


Wirtschaft »

Pivotal phase III CLL14 results for Venclexta/Venclyxto in combination with Gazyva/Gazyvaro for chronic lymphocytic leukaemia presented at ASCO 2019 and published in the New England Journal of Medicine

2019-06-04 19:20:00


Wirtschaft »

Roche presents data from across its breast cancer portfolio at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting

2019-06-03 06:20:42


Wirtschaft »

Roche’s Tecentriq in combination with Avastin and chemotherapy for the initial treatment of people with a specific type of metastatic lung cancer shows positive data in those with liver metastases

2019-06-02 12:20:56



Suchresultate als RSS-Feed